Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
It sits within the regulatory layer covering laboratory reagents and research chemicals
Insurance Coverage Realities Insurance coverage creates the biggest practical difference between these medications
A fresh and sparkling opening
Eylea (aflibercept) Disease area(s): Ophthalmology Manufacturer(s): Regeneron/Bayer 2024 Sales (USD): $9.55 billion Why it sold so well: Eylea registered strong sales in 2024, driven by the introduction of Eylea HD, which received FDA approval in 2023 and is an 8 mg formulation offering extended dosing intervals for retinal diseases
US$ 23.17
US$ 20.90
US$ 21.70
